Photo of Katy Moncivais, Ph.D.

Katy Moncivais, Ph.D.

Medical Editor

Credentials and Professional Experience

  • Rice University (B.S.)
  • The University of Texas at Austin (M.S., Ph.D.)
  • Cover-Featured Article in Experimental and Molecular Medicine 2013
  • Chapter Author for Methods in Molecular Biology
  • Featured Speaker at the 2018 Medical Advancement Expo
  • University of Texas at Austin College of Engineering THRUST Fellow
  • Co-Inventor of US9463069B2 and US20160114078A1

About Katy Moncivais, Ph.D.

Katy Moncivais holds a Ph.D. in Biomedical Engineering from The University of Texas at Austin. She’s an experienced Regenerative Medicine Consultant with a demonstrated history of working in the hospital & healthcare industry. Skilled in adult stem cells, medical devices, biomechanics, bacterial and mammalian cell culture, and regenerative medicine, she provides guidance on an array of topics affecting consumers. She gives presentations and has been published on a variety of scientific and clinical research topics.

In her role at ConsumerSafety.org, Dr. Moncivais works alongside the writing and research staff to help deliver fact-based news stories to consumers. Her unique professional history alongside her rigorous educational background allows her to contribute to a variety of consumer-focused topics with a fresh perspective. In addition, Dr. Moncivais reviews portions of medically driven content to ensure scientific accuracy.

Stories by Katy Moncivais, Ph.D.

Safety
Introducing “Hidden Harms” – An Interactive Exploration of Drug and Medical Device Risks
ConsumerSafety.org is pleased to announce the results of a several-month-long investigation into the risks and dangerous side effects hidden within the dense pages of […]
September 12, 2019
Author Katy Moncivais, Ph.D.
Read More
Health
9/11 First Responders Are Still Dying
Last week, we discussed compensation legislation that benefits 9/11 first responders and survivors and the most recent bill passed in 2019—The Never Forget  the […]
September 11, 2019
Author Katy Moncivais, Ph.D.
Read More
Health
9/11 Health Effects on First Responders
When terrorists flew commercial jets into the World Trade Center (WTC) and the Pentagon on September 11, 2001, the entire nation reeled at the […]
August 28, 2019
Author Katy Moncivais, Ph.D.
Read More
Medical Devices
FDA Links Breast Implants to Cancer, Allergan Issues Global Recall
Top Three Messages for Breast Implant Recipients Specific models of Allergan breast implants are associated with 6x greater risk of breast implant-associated anaplastic large […]
July 26, 2019
Author Katy Moncivais, Ph.D.
Read More
Drugs
Uloric vs Allopurinol
Top 3 Differences Between Uloric & Allopurinol Gout Drugs: Uloric patients had a 34% higher risk of cardiovascular death and 22% higher risk of […]
July 11, 2019
Author Katy Moncivais, Ph.D.
Read More
Drugs
Discontinued FDA Reporting Program Hid Millions of Adverse Events
The U.S. Food and Drug Administration (FDA) recently announced the end of a controversial reporting program that allowed private submission of certain medical device […]
May 22, 2019
Author Katy Moncivais, Ph.D.
Read More
Drugs
Anticoagulant Antidotes: A Safety Requirement
Blood thinners, or anticoagulants, interfere with the body’s clotting mechanisms in an effort to decrease the risks of clot, stroke, embolism and deep vein […]
May 2, 2019
Author Katy Moncivais, Ph.D.
Read More
Drugs
What Is Off-Label Drug Use?
The term “off-label drug use” sounds pretty serious, like it might be risky or illegal, but it’s actually very common. Still, if you read […]
April 19, 2019
Author Katy Moncivais, Ph.D.
Read More
Legal
3M Earplug Lawsuits Transferred to MDL
This week a federal judicial panel consolidated more than 640 lawsuits alleging 3M’s defective military earplugs caused hearing damage and loss. The cases were […]
April 5, 2019
Author Katy Moncivais, Ph.D.
Read More
Legal
Johnson & Johnson Settled Three Talc-Related Mesothelioma Lawsuits
Lawyers for Johnson & Johnson settled several talcum powder lawsuits last week, creating abundant speculation about changes to their legal strategy. In keeping with […]
April 3, 2019
Author Katy Moncivais, Ph.D.
Read More
Drugs
$775 Million Xarelto Settlement for 25,000 Pending Lawsuits
Court documents released Monday indicate Bayer and Johnson and Johnson will settle all federal Xarelto blood thinner lawsuits. The $775 million settlement will be […]
March 25, 2019
Author Katy Moncivais, Ph.D.
Read More
Drugs
Scott Gottlieb: The FDA Commissioner America Needed
Dr. Scott Gottlieb announced his resignation as FDA Commissioner just a couple of weeks ago and will officially leave the agency in a just […]
March 19, 2019
Author Katy Moncivais, Ph.D.
Read More